Inflectra (Infliximab-dyyb) is a biosimilar of Remicade. It is indicated for the treatment of Crohn’s Disease, pediatric Crohn’s Disease, Ulcerative Colitis, Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis and Plaque Psoriasis. Inflectra is administered as an intravenous infusion.
Inflectra infusions are generally administered every six to eight weeks, and infusions are given over a period of about 2 hours. Infusions may be given more frequently at the start of therapy, known as the induction period. Sometimes pre-medications are administered prior to infusions, such as steroids, benadryl, or tylenol. An observation time may be required after your infusion.
Potential Side Effects
The most common side effects of Inflectra include respiratory infections, cough, stomach pain and headache.
Inflectra can lower the ability of your immune system to fight infections.
Your doctor should test you for tuberculosis and hepatitis B before starting Inflectra.
Before you attend your first appointment at Sage Infusion, please make sure to review the documents below. The Patient Consent Form and HIPAA Privacy Authorization Form need to be filled out and signed ahead of your appointment, whereas the Notice of Privacy Practices, Patient Rights and Responsibilities, and Appointment Lateness and Cancelation are for reference only. Please contact us if you have any questions!
Find a Sage Infusion Location Near You
We offer expert infusion therapy without the hassle or cost of the hospital. We employ highly trained medical staff that work with health insurance companies & physicians to provide our patients with convenient care.
SEARCH BY ZIP